Skip to main content
OpenTrials

Clinical trial condition

Stargardt Disease

Explore clinical trials studying Stargardt Disease. Study availability and eligibility vary by location and protocol.

39 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Stargardt Disease trial results

Completed

Safety and Efficacy of Emixustat in Stargardt Disease

NCT03772665

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • UCSF Dept. of Ophthalmology San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
  • The Wilmer Eye Institute Johns Hopkins University Baltimore, Maryland, United States
View all 29 locations
View Trial Details
Completed

This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease

NCT05266014

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Sydney Children's Hospitals Network Westmead, New South Wales, Australia
  • Lions Eye Institute Perth, Western Australia, Australia
  • National Taiwan University Hospital Taipei, Taiwan
View Trial Details
Completed

A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies

NCT01977846

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Greater Baltimore Medical Center Baltimore, Maryland, United States
  • Wilmer Eye Institute, Johns Hopkins University Baltimore, Maryland, United States
  • Cole Eye Institute, Cleveland Clinic Cleveland, Ohio, United States
  • Scheie Eye Institute, University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy

NCT02410122

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Wilmer Eye Institute Baltimore, Maryland, United States
  • Retina Foundation of the Southwest Dallas, Texas, United States
  • Universitäts-Augenklinik Bonn Bonn, Germany
  • Center for Opthalmic Research, University of Tuebingen Tübingen, Germany
View Trial Details

Related conditions